Blueprint library/PAT / RTRT

Pharmaceutical PAT & Real-Time Release Testing Software

Process signal to quality prediction. Prediction to an authorized release decision.

Govern PAT methods, sensors, chemometric models, calibration sets, predictions, process actions, model lifecycle, RTRT strategies, fallback testing, and batch-release evidence.

PAT inference and RTRT decision
Source signal, model pipeline, applicability domain, control action and material coverage form one reproducible release argument.
A process analytical signal passing through quality, chemometric model, control and real-time release gates
Signal
Native spectra retain sensor, method, time, context and integrity.
Quality gate
Noise, range and domain are accepted before inference.
Prediction
The exact preprocessing and released model produce the value.
RTRT
Coverage and approved fallback support the attribute decision.

Process analytical technology becomes release evidence only when the complete inference is controlled: the right material passed the right sensor under the right process state, an approved model transformed acceptable source data into a prediction, the prediction stayed within its applicability domain, required process actions occurred, and the effective release strategy permits that evidence to decide the attribute.

A dashboard showing a smooth NIR trace is not that argument. The operational system must preserve source spectra, model and preprocessing versions, calibration lineage, context, exclusions, uncertainty, process response, fallback path, and the batch decision.

PAT inference and RTRT decision
Source signal, model pipeline, applicability domain, control action and material coverage form one reproducible release argument.
A process analytical signal passing through quality, chemometric model, control and real-time release gates
Signal
Native spectra retain sensor, method, time, context and integrity.
Quality gate
Noise, range and domain are accepted before inference.
Prediction
The exact preprocessing and released model produce the value.
RTRT
Coverage and approved fallback support the attribute decision.
Fig. 1 / A PAT observation resolved through signal quality, an approved model, control action, and RTRT disposition
01

The PAT use case starts with the quality decision

Product, material state, unit operation, critical quality attribute, process parameter, sampling domain, intended prediction, control role, and release role define the use case.

Monitoring, endpoint detection, feed-forward control, feedback control, diversion, and real-time release have different evidence obligations. One method may support several roles, but each is separately authorized.

02

The measurement interface is part of the method

Probe or sensor model, serial, window or flow cell, installation point, insertion depth, optical path, sampling geometry, process contact, range, resolution, acquisition rate, software, communication, and clock form the measurement configuration.

A calibrated analyzer connected at the wrong position or operated with an unapproved acquisition method cannot create valid predictions.

03

Source data remains native and attributable

Spectra, chromatograms, images, acoustic signals, particle measurements, process values, timestamps, diagnostics, instrument methods, dark or reference measurements, and acquisition audit trails remain preserved in native or lossless form.

Seal indexes and contextualizes source evidence without pretending every high-frequency point should be copied into a transactional database.

04

Signal-quality rules gate model execution

Noise, saturation, detector temperature, fouling, bubbles, missing scans, motion, baseline shift, reference failure, synchronization, process-state mismatch, and out-of-domain inputs can invalidate a prediction before its value is considered.

The quality flag and reason accompany every accepted, rejected, substituted, or repeated observation. Bad data is not silently averaged into an acceptable result.

05

Preprocessing is a versioned analytical operation

Wavelength selection, derivatives, smoothing, scatter correction, baseline treatment, normalization, outlier detection, spectral averaging, and data alignment are part of the approved model pipeline.

Each prediction records the exact ordered preprocessing version. A software update that changes a numerical library can therefore be assessed against the functions it affects.

06

Calibration sets preserve scientific representativeness

Samples connect spectra or process observations to reference results, material and process ranges, batches, sites, equipment, suppliers, seasons, scales, analysts, methods, and exclusions.

Training, internal validation, external validation, challenge, and monitoring populations stay distinct. A sample removed from calibration retains who excluded it, why, and what performance changed.

07

The model is a controlled versioned object

Algorithm, coefficients, latent variables or architecture, preprocessing, calibration set, response, range, performance metrics, uncertainty, outlier rules, applicability domain, software environment, intended use, and approval form the model version.

Exploratory models can coexist without becoming production authority. Only the released model and configured endpoint may control or release material.

08

Prediction context prevents orphan numbers

Every prediction links source data, sensor state, model version, material population, process phase, equipment, recipe, timestamp, value, uncertainty, quality flags, domain assessment, and resulting action.

This context supports reproduction and distinguishes a process decision from an analyst's later retrospective calculation.

A PAT model moves through calibration, independent validation, release, performance monitoring, challenge, and controlled update
Fig. 2 / A PAT model moves through calibration, independent validation, release, performance monitoring, challenge, and controlled update
09

Process-control rules are separate from the model

The model may predict moisture, blend uniformity, concentration, coating endpoint, particle attribute, or reaction completion. A separate approved rule defines target, hysteresis, persistence, voting, minimum and maximum process time, fail-safe behavior, action, and operator authority.

This separation allows the same analytical output to support monitoring and control under different process recipes without changing scientific model identity.

10

Diversion and material boundaries remain exact

Continuous or semi-continuous processes require time and residence-time alignment between measurement, material segment, control action, diversion gate, collection container, and downstream lot.

The record identifies which physical material was accepted, diverted, reprocessed where allowed, sampled, or rejected—even when the process never stops.

11

RTRT is an approved attribute-level strategy

The plan identifies product, market, batch type, quality attribute, PAT method, model, process controls, material coverage, acceptance criteria, prerequisite controls, uncertainty treatment, review, and conventional fallback method.

The EU GMP Annex 17 makes clear that RTRT results from an approved control strategy and does not remove the need to comply with a finished-product specification. Seal preserves that relationship per attribute and market.

12

The fallback path is designed before failure

Analyzer outage, probe damage, communication loss, unacceptable signal, model-domain failure, atypical process, calibration concern, or missing coverage resolves an approved fallback: conventional sampling and testing, alternate PAT, additional processing, hold, or rejection.

Fallback eligibility can depend on when failure occurred and whether representative material remains available. It is not improvised at release.

13

Batch evidence accounts for coverage

Review shows expected versus received observations, acceptable signal intervals, model applicability, process phases, endpoints, actions, diversions, unmeasured gaps, fallback tests, deviations, and attribute decisions.

A passing average cannot mask an unmeasured critical interval or a prediction produced outside the model's approved domain.

14

Model performance is monitored against reference truth

Prediction bias, residuals, error, outlier frequency, leverage or distance, range coverage, process drift, material shifts, instrument differences, and reference-method performance are trended using governed populations.

Scheduled and triggered challenge samples connect PAT predictions to independent laboratory results. Trending distinguishes model change from reference-method or sample-handling change.

15

Changes evaluate both science and implementation

Sensor, optical part, instrument firmware, acquisition method, preprocessing code, model, calibration sample, reference method, material supplier, formulation, process range, scale, equipment, site, or control rule can affect suitability.

Impact identifies required bridging, recalibration, independent validation, software assurance, process validation, regulatory action, and prospective monitoring before the changed state becomes authoritative.

16

Where Seal is strongest

Seal is strongest at the handoff from high-frequency analytical technology to regulated material state. Instruments and historians retain dense source data; control systems execute deterministic actions; Seal binds the scientific version, process context, physical population, exceptions, and release authority.

That architecture supports NIR, Raman, imaging, particle analysis, spectroscopy, multivariate sensors, soft sensors, and hybrid models without treating all PAT as one generic time-series chart.

17

Prove one difficult batch end to end

The first implementation should follow one blend-uniformity RTRT use case through approved method and sensor configuration, calibration samples, model validation and release, instrument readiness, raw spectra, signal-quality rejection, predictions, endpoint rule, process action, coverage review, fallback laboratory test, attribute decision, batch release, performance monitoring, and later model update.

Include a probe replacement, clock offset, out-of-domain spectrum, excluded calibration sample, model bias signal, one unmeasured interval, endpoint override, conventional fallback, and a material-supplier shift. The first usable release must reproduce every accepted prediction and identify the exact material whose decision depended on it.

Operating model

Native control model
States and decisions owned by this blueprint
06 native controls
PAT Use Case & Measurement Context
Product, process, material domain, CQA, sensor position, geometry, acquisition, monitoring, endpoint, control, and release roles define what the measurement may support.
Signal Quality & Prediction Lineage
Native source files, diagnostics, clocks, process phase, preprocessing, model version, value, uncertainty, domain assessment, flags, exclusions, and actions remain reproducible.
Chemometric Model Lifecycle
Calibration and validation populations, reference truth, exclusions, algorithms, coefficients, preprocessing, metrics, range, uncertainty, approval, deployment, and retirement stay governed.
Process Control & Material Diversion
Targets, persistence, hysteresis, voting, endpoints, adjustments, fail-safe actions, overrides, residence-time alignment, diversion, containers, and physical material genealogy connect.
Attribute-Level RTRT Strategy
Product and market, attributes, PAT methods, models, process controls, coverage, criteria, uncertainty, conventional fallback, evidence review, and release authority remain explicit.
Model Performance & Change Impact
Bias, residuals, outliers, domain, drift, reference comparisons, sensors, software, material, process, scale, site, model and control-rule changes trigger proportionate action.
Connected foundations
Existing blueprints supplying governed records and execution
10 foundations
EBRElectronic Batch Record Software
Author, execute, review, and release GMP batch records with material and equipment checks, automated data capture, controlled exceptions, and complete history.
sdmsScientific Data Management System (SDMS) Software
Automatically capture scientific instrument and application data, preserve original files and metadata, prove file-set completeness and integrity, connect data to samples and work, govern review and derived versions, search across formats, retain and restore records, and manage migrations and legal holds.
CPVContinued Process Verification Software
Monitor version-aware process parameters, material attributes, equipment, yields, holds, deviations, and quality attributes with governed populations, signals, and actions.
limsPharmaceutical QC LIMS Software
Seal checks results against live specs. AI-configured methods evolve with your process. Unified with MES, QMS, and ELN.
SpecificationsPharmaceutical Specification Management Software
Control material, in-process, release, and stability specifications across products, sites, markets, methods, sampling plans, lifecycle stages, changes, testing, and disposition.
CalibrationPharmaceutical Calibration & Metrology Management Software
Control instrument ranges, procedures, reference standards, due work, as-found and as-left data, uncertainty, tolerances, out-of-tolerance impact, labels, and use eligibility.
MethodsAnalytical Method Lifecycle, Validation & Transfer Software
Connect analytical target profiles, development knowledge, validation characteristics, transfer protocols, method versions, instruments, specifications, and routine monitoring.
PVPharmaceutical Process Validation & PPQ Software
Plan and execute process performance qualification, govern readiness and acceptance criteria, connect manufacturing and laboratory evidence, resolve deviations, calculate capability, approve validation conclusions, and hand the proven process into continued verification.
BRPharmaceutical Batch Review & Release Software
Plan batch-release evidence from the approved product state, review execution and testing concurrently, resolve exceptions, control market eligibility, generate CoAs, and sign an accountable disposition.
ChangeGxP Change Control Software
CC-2024-047 was approved in January. Six months later, the procedure still showed the old process. Implementation tracking that ensures changes actually happen.
Pharmaceutical PAT & Real-Time Release Testing Software owns the operating state above; connected foundations remain authoritative for their specialized records.

Capabilities

Product, process, material domain, CQA, sensor position, geometry, acquisition, monitoring, endpoint, control, and release roles define what the measurement may support.
Native source files, diagnostics, clocks, process phase, preprocessing, model version, value, uncertainty, domain assessment, flags, exclusions, and actions remain reproducible.
Calibration and validation populations, reference truth, exclusions, algorithms, coefficients, preprocessing, metrics, range, uncertainty, approval, deployment, and retirement stay governed.
Targets, persistence, hysteresis, voting, endpoints, adjustments, fail-safe actions, overrides, residence-time alignment, diversion, containers, and physical material genealogy connect.
Product and market, attributes, PAT methods, models, process controls, coverage, criteria, uncertainty, conventional fallback, evidence review, and release authority remain explicit.
06BRconnected foundationBatch Coverage & Disposition
Expected and received intervals, signal validity, domain, phases, endpoints, diversions, gaps, fallback tests, exceptions, attribute decisions, and batch release form one review.
Instrument, probe, installation, range, diagnostics, calibration or verification, maintenance, reference materials, clock, software, and replacement state gate prediction use.
Bias, residuals, outliers, domain, drift, reference comparisons, sensors, software, material, process, scale, site, model and control-rule changes trigger proportionate action.

Entities

Entity
Description
Kind
T
PAT Use Case
Product, process, quality attribute, material domain, analytical role, control role, release role, and authority.
type
T
NIR Blend Uniformity RTRT
In-line spectra, blend-domain model, endpoint control, coverage, fallback sampling, and release role.
template
T
PAT-BU-OSD-004 / v06
Approved commercial use case for two strengths on Blender BL-04.
instance
LT
PAT Method
Technique, acquisition, measurement geometry, preprocessing, performance, limitations, and effective version.
type
P
PAT Sensor Configuration
Instrument, probe, serial, position, path, range, software, acquisition, clock, and readiness.
type
TL
PAT Source Observation
Native signal, timestamp, diagnostics, method, sensor, process state, checksum, and quality flags.
type
SP
Calibration Set
Samples, observations, reference values, populations, ranges, exclusions, roles, and approved version.
type
PA
Chemometric Model
Algorithm, preprocessing, calibration, output, range, metrics, uncertainty, domain, software, and state.
type
PA
PLS Quantitative Model
Preprocessing, selected range, latent variables, calibration, validation, error, domain, and release.
template
PA
MODEL-BU-4.2.1
Released model trained on 184 batches with independent external validation.
instance
N
PAT Prediction
Source, model, context, value, uncertainty, domain, quality, material segment, and resulting use.
type
N
Contextual PAT Prediction
Source signal, model and pipeline, process phase, material segment, result, uncertainty, domain, and action.
template
N
PRED-B260801-00842
Accepted blend-uniformity prediction at minute 14.2 within the approved spectral domain.
instance
C
Process Control Rule
Prediction, target, persistence, hysteresis, timing, voting, fail-safe, action, and override authority.
type
AU
PAT Process Action
Rule, prediction, command, equipment response, endpoint, adjustment, diversion, override, and confirmation.
type
SC
Measured Material Segment
Material, batch, process time, residence alignment, path, quantity, container, acceptance, and genealogy.
type
E
RTRT Attribute Strategy
Attribute, market, PAT evidence, controls, coverage, acceptance, uncertainty, fallback, and review.
type
F
RTRT Fallback Execution
Trigger, affected interval, alternate sampling or method, eligibility, result, impact, and authorization.
type
F
Analyzer-Outage Fallback
Failure timing, material coverage, conventional sample plan, laboratory method, hold, and decision.
template
F
FALLBACK-B260801
Composite laboratory sampling used for a 3.4-minute unmeasured process interval.
instance

FAQ

It governs process analytical methods, sensors, native signals, signal-quality rules, models, predictions, process context, actions, material scope, lifecycle performance, and their use in quality decisions.
RTRT uses approved process understanding, measurements, models, controls, and acceptance logic to evaluate specified quality attributes during manufacture instead of relying only on end-product testing.
No. The approved control strategy defines how each specification attribute is assured and which PAT or conventional evidence supports its decision for the effective product and market.
Seal can preserve or reference native spectra and other source data in governed storage while indexing checksum, instrument, method, time, process context, quality flags, model use, and retention.
Each version includes algorithm, preprocessing, calibration and validation sets, coefficients or architecture, performance, uncertainty, applicability domain, software environment, intended use, approval, and deployment.
Approved signal-quality and applicability rules evaluate diagnostics, spectral or multivariate distance, process context, range, instrument state, and other method-specific criteria before a prediction is accepted.
Control systems should execute deterministic control. Seal governs the approved model and control rule, captures predictions and actions, aligns them to material, and preserves exceptions and decision evidence.
Measurements and actions align by process time and residence-time model to material segments, diversion gates, collection containers, quantities, and downstream lots.
A preapproved fallback resolves from failure type and timing, available material, representative sampling, alternate PAT or conventional method, process action, hold, and authorization.
Predictions are compared with governed reference results and trended for bias, residuals, error, outliers, domain, material and process range, instruments, suppliers, and temporal shifts.
Sensors, optical components, firmware, acquisition, preprocessing, software, calibration samples, reference methods, materials, formulations, ranges, scale, equipment, site, and control rules can all trigger impact.
Prove one attribute from source signal through quality gating, approved model, prediction, process action, material coverage, fallback, release decision, performance monitoring, and controlled model change.

Related blueprints

ContinuousContinuous Pharmaceutical Manufacturing Software

Material moves through time. Every disturbance, residence window, control action, diversion, collection, and batch boundary reconstructed.

Operate continuous drug-substance and drug-product processes with time-based material genealogy, residence-time distributions, process-state classification, PAT and active controls, disturbance management, diversion, collection, batch definition, review, validation, and release.

Compendial ChangePharmacopoeial & Compendial Change Management Software

Publication change to affected monograph. Monograph to every material, method, specification, product, filing, and implementation deadline.

Monitor USP, Ph. Eur., JP and other compendial changes, compare requirements, calculate product and market impact, evaluate methods and specifications, plan laboratory and regulatory evidence, govern dual-state implementation, and prove timely compliance.

Visual InspectionPharmaceutical Visual Inspection & Defect Management Software

Every inspected unit. Every defect decision. One reconciled population.

Govern manual and automated visual inspection, defect libraries, inspector qualification, challenge sets, reject genealogy, investigations, reconciliation, trending, and finished-batch disposition.

msatMSAT Process Knowledge & Manufacturing Support Software

Development intent to manufacturing reality. Every signal, investigation, change, and transfer strengthens the process model.

Run Manufacturing Science and Technology across process ownership, technology transfer, site and product knowledge, batch monitoring, process signals, investigations, change impact, validation and CPV, improvement, comparability, commitments, and governed manufacturing support.

LyophilizationPharmaceutical Lyophilization & Freeze-Drying Cycle Management Software

Filled vial to dried cake. Every load position, phase transition, alarm, and release decision connected.

Govern lyophilization recipes, product and load configurations, loading and stoppering, chamber readiness, source cycle data, endpoints, exceptions, unload genealogy, quality results, validation, and release.

CCITContainer Closure Integrity Testing (CCIT) Software

Package configuration to leak path. Method capability to shelf-life claim. Every integrity conclusion traceable.

Govern container-closure configurations, critical quality attributes, CCIT methods, positive controls and standards, validation, routine and stability studies, transport challenges, results, investigations, trending, and lifecycle decisions.

Go live in 48 hours.